Form 4: Zymeworks Executive Acquires Stock Options and Restricted Stock Units

Leone D. Patterson, EVP, Chief Bus & Fin Officer at Zymeworks Inc., acquired 79,000 stock options and 53,000 restricted stock units on January 10, 2025.

Summary

• Leone D. Patterson, an executive at Zymeworks Inc., has reported the acquisition of 79,000 stock options and 53,000 restricted stock units.
• The stock options have an exercise price of $13.22 and vest over a period of 4 years, with 25% vesting on the first anniversary of the grant date and the remainder vesting monthly over the following 3 years.
• The restricted stock units (RSUs) vest in three equal annual installments starting on the first anniversary of the grant date.
• Both the stock options and RSUs were granted on January 10, 2025.

Sentiment

Score: 7

Explanation: The document reflects a standard executive compensation practice, which is generally viewed positively as it aligns management's interests with shareholders. There are no negative implications.

Positives

• The acquisition of stock options and RSUs by a key executive suggests confidence in the company's future performance.
• The vesting schedule of the stock options and RSUs aligns the executive's interests with the long-term success of the company.

Industry Context

This is a standard practice for incentivizing executives in publicly traded companies, particularly in the biotechnology sector where long-term growth is a key focus.

Comparison to Industry Standards

• Stock option and RSU grants are common forms of executive compensation in the biotechnology industry.
• Vesting schedules, such as the ones described, are typical to ensure long-term commitment from executives.
• Companies like Amgen, Regeneron, and Gilead Sciences also use similar equity-based compensation plans for their executives.

Stakeholder Impact

• Shareholders may view this as a positive sign of management's commitment to the company's long-term success.
• Employees may see this as a positive sign of the company's financial health and commitment to its leadership.

Key Dates

Keywords

stock options, restricted stock units, executive compensation, insider trading, Zymeworks, ZYME, equity